Investors with a 6 to 12 month horizon may consider them. They should align their holding period with the fund's maturity profile and prefer schemes with a lower expense ratio.
Investors are moving away from the commercial paper (CP) market towards certificates of deposit (CDs), as primary CD issuances and rates on these short-term instruments rise.
Dhawal Dalal, executive vice-president & head, fixed income, DSP BlackRock Investment Managers, expects the central bank to hold rates for the rest of calendar year 2016.
Investors not comfortable investing directly may take the mutual fund route, where they get exposure to a diversified portfolio of bonds.
West Zone will be without key players Rohit Sharma and Dhawal Kulkarni in their D B Deodhar Trophy campaign after injuries ruled them out of the One-day tournament, which started on Sunday in Guwahati.
In the state of the economy report, the RBI said bond vigilantes could undermine the recovery, unsettle financial markets, and trigger capital outflows from emerging markets.
These schemes are expected to perform in the next 2-3 years.
Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past year with a return of over 30 per cent. The gains have come on the back of multiple triggers such as the scaling up of new product launches in the US market, clearance for its Moraiya (Gujarat) facility and steady performance in the domestic market. Though it has been the top pharma gainer in the 2022-23 financial year (FY23), brokerages continue to maintain their 'buy' stance, given the strong visibility in the US market.
India's third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy's Laboratories (DRL) and private equity (PE) giant Blackstone. Analysts say it is more likely for a strategic investor like Torrent or DRL to acquire Cipla than a PE firm, which may not derive healthy returns at Cipla's current market price (CMP) after the recent gains.
When Mizoram batted, Shreevats Goswami (31) was the only significant scorer but the seasoned Mumbai attack led by Dhawal Kulkarni kept the minnows under check.
India's largest listed pharmaceutical (pharma) company - Sun Pharmaceutical Industries (Sun Pharma) - is expected to maintain its outperformance vis--vis the sector's, as its multiple bets on specialty products, improving product mix, recent acquisitions, and branded business are finding favour with brokerages. While it has gained 7 per cent over the past year, the Nifty Pharma Index is down 13.6 per cent. Its outperformance over two years has been fairly evident, with the market leader gaining 66 per cent to Nifty Pharma's minus 1.4 per cent.
Veteran batsman Wasim Jaffer will lead Mumbai in their four-day Ranji Trophy Group A match against Orissa, at the Wankhede stadium, from December 14, as Abhishek Nayar is injured.
Exposure to debt funds and gold is essential even if current returns from these asset classes are low, suggests Sanjay Kumar Singh.
This was Mumbai's second successive win after they had beaten Delhi in the lung-opener.
Mumbai trounced Himachal Pradesh by 200 runs in their final Elite Group D game to remain unbeaten in the league stage
Test specialist Cheteshwar Pujara continued his good form with the bat as he and Robin Uthappa helped Saurashtra crush Punjab by eight wickets.
590 cricketers -- including 370 Indian players and 220 overseas players -- will go under the hammer during the two-day mega auction in Bengaluru on February 12 and 13.
In the other matches, Manipur trounced Nagaland by 10 wickets in the battle of newcomers while Jammu and Kashmir defeated Andhra Pradesh by five wickets.
Hosts Karnataka amassed three points on the basis of their crucial first-innings lead as their Elite Ranji Trophy Group A game against Mumbai ended in a tame draw in Belagavi.
Delhi suffered another batting collapse to brighten Punjab's prospects of recording an outright victory in their Ranji Trophy Group B match in New Delhi on Thursday.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances